← Eichor
Study identifier: NCT06302985 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Atomized Inhalation ICG for Treatment of Congenital Lung Malformations

Condition: Pulmonary Sequestration · Congenital Pulmonary Airway Malformation · Indocyanine Green  ·  Sponsor: Jiexiong Feng

PhaseNA
Planned participants50
Who can joinAll sexes, 3 Months to 14 Years
Healthy volunteersNo

About this study

To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.

This description comes directly from the study's public registry record.

Talk to the study team

Tianqi Zhu, MD  ·  0086-13986295423  ·  zhutianqi84@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tongji HospitalWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06302985